{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T08:01:02Z","timestamp":1772006462581,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005366","name":"Universitetet i Oslo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Platelet activation is documented in COVID-19, but data on platelet-derived mediators are scarce.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the levels of various platelet-derived mediators in relation to adverse outcomes defined as the need for treatment at intensive care unit (ICU) and\/or respiratory failure (RF) and 60-day total mortality in hospitalized COVID-19 patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Plasma levels of RANTES\/CCL5, PF4\/CXCL4, ENA78\/CXCL5, NAP-2\/CXCL7, SDF-1\/CXCL12, P-selectin, soluble CD40 ligand (sCD40L) and vascular endothelial cell growth factor A (VEGF-A) were measured in 245 hospitalized COVID-19 patients and in a subpopulation of the patients, also at three, six and 12 months after hospitalization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our main findings were: (i) High levels of P-selectin was associated with ICU\/RF, while low levels of PF4\/CXCL4, ENA-78\/CXCL5 and NAP-2\/CXCL7 were associated with 60-days mortality. (ii) Most of the mediators were normalized after hospitalization, but plasma levels of sCD40L, ENA-78\/CXCL7 and VEGF-A were markedly elevated compared to healthy controls for up to 12 months after hospitalization. (iii)\n                      <jats:italic>In vitro<\/jats:italic>\n                      , inactivated SARS-CoV-2 induced a dose-dependent release of NAP-2, P-selectin, RANTES, sCD40L and VEGF-A from isolated platelets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings underscore the role of platelet-derived inflammatory mediators in the pathogenesis of COVID-19, potentially involving direct effects of SARS-CoV-2. The study also points to a persistent platelet activation following hospitalization.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1685861","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:04:49Z","timestamp":1772003089000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Platelet-derived mediators in hospitalized COVID-19 patients and associations to respiratory failure, ICU admittance and 60-day mortality"],"prefix":"10.3389","volume":"13","author":[{"given":"Kari","family":"Otterdal","sequence":"first","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway","place":["Troms\u00f8, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Cato","family":"Holter","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Department of Microbiology, Oslo University Hospital","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Kaarb\u00f8","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Oslo University Hospital","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ylva","family":"Schanke","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beathe Kiland","family":"Granerud","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Department of Microbiology, Oslo University Hospital","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuva B.","family":"Dahl","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Tveita","sequence":"additional","affiliation":[{"name":"Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital","place":["Oslo, Norway"]},{"name":"Department of Internal Medicine, B\u00e6rum Hospital, Vestre Viken Hospital Trust","place":["Gjettum, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders Benjamin","family":"Kildal","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, University Hospital of North Norway","place":["Troms\u00f8, Norway"]},{"name":"Department of Clinical Medicine, Faculty of Health Science, UIT-The Arctic University of Norway","place":["Troms\u00f8, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Heggelund","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Drammen Hospital, Vestre Viken Hospital Trust","place":["Drammen, Norway"]},{"name":"Department of Clinical Science, Faculty of Medicine, University of Bergen","place":["Bergen, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Hege","family":"Aamodt","sequence":"additional","affiliation":[{"name":"Department of Neurology, Oslo University Hospital","place":["Oslo, Norway"]},{"name":"Department of Neuromedicine and Movement Science, the Norwegian University of Science and Technology","place":["Trondheim, Norway"]},{"name":"Institute of Population Health, Faculty of Health and Life Sciences, University of Liverpool","place":["Liverpool, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksander Rygh","family":"Holten","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Department of Acute Medicine, Oslo University Hospital","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian","family":"Tonby","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Department of Infectious Diseases, Oslo University Hospital","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Ma","family":"Dyrhol-Riise","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]},{"name":"Department of Infectious Diseases, Oslo University Hospital","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bente","family":"Halvorsen","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annika E.","family":"Michelsen","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, Oslo University Hospital Rikshospitalet","place":["Oslo, Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo","place":["Oslo, Norway"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"807934","DOI":"10.3389\/fimmu.2022.807934","article-title":"The COVID complex: a review of platelet activation and immune complexes in COVID-19","volume":"13","author":"Jevtic","year":"2022","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1161\/CIRCRESAHA.122.321930","article-title":"Platelets and SARS-CoV-2 during COVID-19: immunity, thrombosis, and beyond","volume":"132","author":"Sciaudone","year":"2023","journal-title":"Circ Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1080\/09537104.2021.1962519","article-title":"Alterations in platelets during SARS-CoV-2 infection","volume":"33","author":"Brambilla","year":"2022","journal-title":"Platelets"},{"key":"B4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1055\/s-0042-1749441","article-title":"Platelet activation and thrombosis in COVID-19","volume":"49","author":"Iba","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e12642","DOI":"10.1002\/rth2.12642","article-title":"The ongoing enigma of SARS-CoV-2 and platelet interaction","volume":"6","author":"Zaid","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1392000","DOI":"10.3389\/fimmu.2024.1392000","article-title":"Does SARS-CoV-2 infect platelets?","volume":"15","author":"Subramaniam","year":"2024","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1111\/jth.15534","article-title":"Platelets contribute to disease severity in COVID-19","volume":"19","author":"Barrett","year":"2021","journal-title":"J Thromb Haemost"},{"key":"B8","doi-asserted-by":"publisher","first-page":"E468","DOI":"10.1002\/ajh.26372","article-title":"Plasma P-selectin is an early marker of thromboembolism in COVID-19","volume":"96","author":"Fenyves","year":"2021","journal-title":"Am J Hematol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1017\/S0950268821000236","article-title":"Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis","volume":"149","author":"Pranata","year":"2021","journal-title":"Epidemiol Infect"},{"key":"B10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cca.2020.03.022","article-title":"Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis","volume":"506","author":"Lippi","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.thromres.2023.07.008","article-title":"Thrombocytopenia is associated with a dysregulated host response in severe COVID-19","volume":"229","author":"Appelman","year":"2023","journal-title":"Thromb Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCRESAHA.122.321659","article-title":"Persisting platelet activation and hyperactivity in COVID-19 survivors","volume":"131","author":"Martins-Goncalves","year":"2022","journal-title":"Circ Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jacbts.2024.09.007","article-title":"Low-grade inflammation in long COVID syndrome sustains a persistent platelet activation associated with lung impairment","volume":"10","author":"Brambilla","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1080\/09537104.2021.1921721","article-title":"Distinct phenotypes of platelet, monocyte, and neutrophil activation occur during the acute and convalescent phase of COVID-19","volume":"32","author":"Chao","year":"2021","journal-title":"Platelets"},{"key":"B15","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41597-022-01534-9","article-title":"ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19","volume":"9","author":"Garcia-Gallo","year":"2022","journal-title":"Sci Data"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jobb.2020.12.001","article-title":"Heat inactivation of the severe acute respiratory syndrome coronavirus 2","volume":"3","author":"Batejat","year":"2021","journal-title":"J Biosaf Biosecur"},{"key":"B17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1002\/cpmc.108","article-title":"An in vitro microneutralization assay for SARS-CoV-2 serology and drug screening","volume":"58","author":"Amanat","year":"2020","journal-title":"Curr Protoc Microbiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.jviromet.2013.06.024","article-title":"Fetal bovine serum inhibits hepatitis C virus attachment to host cells","volume":"193","author":"Qin","year":"2013","journal-title":"J Virol Methods"},{"key":"B20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/jmv.1890130307","article-title":"In vitro neutralization of HSV-2: inhibition by binding of normal IgG and purified fc to virion fc receptor (FcR)","volume":"13","author":"Dowler","year":"1984","journal-title":"J Med Virol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","article-title":"Chemokines and cardiovascular risk","volume":"28","author":"Aukrust","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1055\/s-0038-1656116","article-title":"The origin of P-selectin as a circulating plasma protein","volume":"77","author":"Fijnheer","year":"1997","journal-title":"Thromb Haemost"},{"key":"B24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1600-0609.2004.00342.x","article-title":"Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L","volume":"74","author":"Nagasawa","year":"2005","journal-title":"Eur J Haematol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0008-6363(99)00262-X","article-title":"CXC-chemokines, a new group of cytokines in congestive heart failure\u2013possible role of platelets and monocytes","volume":"45","author":"Damas","year":"2000","journal-title":"Cardiovasc Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1046\/j.1538-7836.2003.00475.x","article-title":"Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region","volume":"1","author":"Arisato","year":"2003","journal-title":"J Thromb Haemost"},{"key":"B27","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/cmi.2017.107","article-title":"The unique structural and functional features of CXCL12","volume":"15","author":"Janssens","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13613-021-00899-1","article-title":"Platelet activation in critically ill COVID-19 patients","volume":"11","author":"Yatim","year":"2021","journal-title":"Ann Intensive Care"},{"key":"B29","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1161\/CIRCULATIONAHA.123.065619","article-title":"P-selectin de-ACTIVation in COVID-19: what have we learned?","volume":"148","author":"Bikdeli","year":"2023","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12985-021-01680-3","article-title":"Platelet-derived sCD40L: specific inflammatory marker for early-stage severe acute respiratory syndrome coronavirus 2 infection","volume":"18","author":"Hamzeh-Cognasse","year":"2021","journal-title":"Virol J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10238-025-01583-5","article-title":"VEGF-A in COVID-19: a systematic review and meta-analytical approach to its prognostic value","volume":"25","author":"Bahreiny","year":"2025","journal-title":"Clin Exp Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.139834","article-title":"Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease","volume":"5","author":"Zhao","year":"2020","journal-title":"JCI Insight"},{"key":"B33","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1086\/427514","article-title":"Chemokine patterns in meningococcal disease","volume":"191","author":"Moller","year":"2005","journal-title":"J Infect Dis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1055\/s-0042-1757163","article-title":"Hyperresponsive platelets and a reduced platelet granule release capacity are associated with severity and mortality in COVID-19 patients","volume":"122","author":"Garishah","year":"2022","journal-title":"Thromb Haemost"},{"key":"B35","doi-asserted-by":"publisher","first-page":"795624","DOI":"10.3389\/fcvm.2021.795624","article-title":"Adverse outcome in COVID-19 is associated with an aggravating hypo-responsive platelet phenotype","volume":"8","author":"Schrottmaier","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1113\/jphysiol.2011.225417","article-title":"Platelets: a critical link between inflammation and microvascular dysfunction","volume":"590","author":"Stokes","year":"2012","journal-title":"J Physiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1038\/mi.2017.1","article-title":"Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection","volume":"10","author":"Guo","year":"2017","journal-title":"Mucosal Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"621","DOI":"10.24272\/j.issn.2095-8137.2020.118","article-title":"Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an in vivo hACE2 transfection mouse model","volume":"41","author":"Liang","year":"2020","journal-title":"Zool Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"914730","DOI":"10.3389\/fphar.2022.914730","article-title":"Multifaceted roles of chemokine C-X-C motif ligand 7 in inflammatory diseases and cancer","volume":"13","author":"Wu","year":"2022","journal-title":"Front Pharmacol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.4161\/cam.3.3.8260","article-title":"Functional diversity of SDF-1 splicing variants","volume":"3","author":"Janowski","year":"2009","journal-title":"Cell Adh Migr"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/jth.12404","article-title":"Platelet-derived CXCL12 (SDF-1alpha): basic mechanisms and clinical implications","volume":"11","author":"Chatterjee","year":"2013","journal-title":"J Thromb Haemost"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.3892\/etm.2020.8433","article-title":"The autocrine CXCR4\/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity","volume":"19","author":"Li","year":"2020","journal-title":"Exp Ther Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"26604","DOI":"10.1038\/s41598-024-77388-5","article-title":"CXCL12\/CXCR4 pathway as a novel therapeutic target for RNF213-associated pulmonary arterial hypertension","volume":"14","author":"Hiraide","year":"2024","journal-title":"Sci Rep"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/thoraxjnl-2016-209170","article-title":"What drives neutrophils to the alveoli in ARDS?","volume":"72","author":"Zemans","year":"2017","journal-title":"Thorax"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v14122665","article-title":"CXCL12 And CXCL13 cytokine Serum levels are associated with the magnitude and the quality of SARS-CoV-2 humoral responses","volume":"14","author":"Noto","year":"2022","journal-title":"Viruses"},{"key":"B46","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00018-023-04870-0","article-title":"Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients","volume":"80","author":"Cambier","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI188222","article-title":"CXCL12 Ameliorates neutrophilia and disease severity in SARS-CoV-2 infection","volume":"135","author":"Zheng","year":"2025","journal-title":"J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"oead119","DOI":"10.1093\/ehjopen\/oead119","article-title":"Increased cardiovascular mortality during the COVID-19 pandemic: do not neglect causality","volume":"3","author":"Halvorsen","year":"2023","journal-title":"Eur Heart J Open"},{"key":"B49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/eurjpc\/zwae070","article-title":"Cardiovascular disease as part of long COVID: a systematic review","volume":"32","author":"Tsampasian","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.atherosclerosis.2014.10.094","article-title":"Plasma stromal cell-derived factor 1alpha\/CXCL12 level predicts long-term adverse cardiovascular outcomes in patients with coronary artery disease","volume":"238","author":"Ghasemzadeh","year":"2015","journal-title":"Atherosclerosis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/01.CIR.0000028962.04520.01","article-title":"Platelet-derived CD40L: the switch-hitting player of cardiovascular disease","volume":"106","author":"Andre","year":"2002","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"765768","DOI":"10.3389\/fphar.2021.765768","article-title":"The role of CXC chemokines in cardiovascular diseases","volume":"12","author":"Lu","year":"2021","journal-title":"Front Pharmacol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biomedicines12051055","article-title":"Vascular endothelial growth factor (VEGF) and its role in the cardiovascular system","volume":"12","author":"Florek","year":"2024","journal-title":"Biomedicines"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/biom14070835","article-title":"Interplay between comorbidities and long COVID: challenges and multidisciplinary approaches","volume":"14","author":"Ashmawy","year":"2024","journal-title":"Biomolecules"},{"key":"B55","doi-asserted-by":"publisher","first-page":"107912","DOI":"10.1016\/j.ijid.2025.107912","article-title":"Impact of pre-existing comorbidities and multimorbidities, demography and viral variants on post-acute sequelae of COVID-19 (\u2018long COVID\u2019) in Dutch primary care: a retrospective cohort study","volume":"156","author":"Berends","year":"2025","journal-title":"Int J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/TA.0000000000002398","article-title":"Female platelets have distinct functional activity compared with male platelets: implications in transfusion practice and treatment of trauma-induced coagulopathy","volume":"87","author":"Coleman","year":"2019","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1685861\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:04:51Z","timestamp":1772003091000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1685861\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":56,"alternative-id":["10.3389\/fcvm.2026.1685861"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1685861","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"article-number":"1685861"}}